October 10, 2012 08:00 ET

Equity Research on AmerisourceBergen Corp. and McKesson Corp. - Drug Wholesalers Capitalizing on Demand Levels

NEW YORK, NY--(Marketwire - Oct 10, 2012) - Companies within the wholesale drug industry continue to be the beneficiaries of strong generic sales in the U.S. Demand for generics is improving and acquisition and deal making activities continue to increase because many companies look to quickly grow sales and stave off competitive threats. Get your free reports on AmerisourceBergen Corporation and McKesson Corp. at There is no commitment to join. has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Drugs Wholesale industry and are offering free analytical research on AmerisourceBergen Corporation (NYSE: ABC) and McKesson Corp. (NYSE: MCK). Register with us now to have free access to these research reports. Simply click on the link below.

On the deal making front, AmerisourceBergen Corp.'s three year, $18.5 billion supply deal with Express Scripts that became effective this month, exemplifies the above trends. The highly lucrative and mutually beneficial deal should facilitate revenue growth and provide stability. AmerisourceBergen Corporation report is accessible for free by registering today at is the Ultimate Trading Environment for investors. If you are considering owning AmerisourceBergen Corporation and McKesson Corp. then you should sign up for a free membership and our complimentary reports today. Over the last 5 years our returns outpaced any of the major indexes. Sign up today by clicking on the link below to find out what you are missing.

Acquisitions are also becoming more frequent as drug wholesalers look to quickly capture market share and widen margins. The latest efforts from McKesson Corp. illustrate the effectiveness of this strategy. It recently inked a definitive agreement to acquire MedVentive to not only grow sales but to also improve efficiency and reduce costs. McKesson Corp. report is accessible for free by registering today at

Moving forward, high levels of competition will likely continue to be the biggest threat to bottom-lines for pharmaceutical distributors at this time. However, current demand levels and the slate of drugs hitting the generic market appear capable of offsetting mounting competition.

The two Drugs Wholesale stocks research reports are available for free by signing up now on the link below.


Shine's Rooms is the brainchild of David Shine, a 13-year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting-edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.

To view our disclaimer, visit this link

Contact Information